Annual Drug Patent Expirations for SAPHRIS
Saphris is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for SAPHRIS.
The generic ingredient in SAPHRIS is asenapine maleate. Two suppliers are listed for this compound. Additional details are available on the asenapine maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com